Last reviewed · How we verify

NCT06931964

Frailty and Assocciated Factors in Sarcopenia

Completed Last updated 16 July 2025
What this trial tests

trial in Sarcopenia in 68 participants. Completed in 20 May 2025.

Timeline
1 June 2024
Primary endpoint
20 May 2025
20 May 2025

Quick facts

Lead sponsorKarabuk University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment68
Start date1 June 2024
Primary completion20 May 2025
Estimated completion20 May 2025
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Karabuk University

Who can join

Adults 65 to 90, any sex, with Sarcopenia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Primary sarcopenia is a condition that occurs with the aging process and is characterized by symptoms such as decreased muscle mass, impaired muscle function and decreased physical strength. The decrease in muscle mass can lead to a decrease in physical strength, balance and mobility, making older people more prone to frailty and falls, which can lead to a fear of falling. Although there are few studies on sarcopenia in the literature, the level of frailty in sarcopenia is related to balance, falls risk and kinesiophobia in sarcopenia. Our aim in the study was to measure frailty in elderly individuals diagnosed with sarcopenia and to determine the level of frailty. to evaluate the effect of sarcopenia on fall risk, balance and kinesiophobia and to evaluate the effect of sarcopenia on fall risk, balance and kinesiophobia according to the results of the evaluation and new rehabilitation programs on frailty, falls, kinesiophobia and balance resulting from sarcopenia and to be the basic data for the programs to be created.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Impact of frailty on balance, fall risk, and kinesiophobia in sarcopenic elderly.
    Yana M, Çoroğlu E, Güneş M, Mermerkaya G, et al · · 2025 · PMID 41350982 · DOI 10.1186/s12877-025-06620-2

Verify or expand the search:

Other recruiting trials for Sarcopenia

Currently open trials in the same condition.

Other Karabuk University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06931964.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing